Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Methotrexate for Uveitis-Associated Macular Edema
NCT01314417Phase 2Terminated
- Sponsor
- National Eye Institute
- Start
- Feb 2011
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in macular edema, sponsored by National Eye Institute. Started Feb 2011; status: terminated.
02
Drugs
methotrexate
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT01314417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01314417.